Reduced use of child sexual abuse material after online CBT
Researchers at Karolinska Institutet have conducted a pioneering study analysing internet-delivered anonymous cognitive behavioural therapy (CBT) for people who view images or videos of children being sexually abused. The participants, who were mainly recruited via forums on the encrypted part of the internet called Darknet, reported less use of such material after therapy. The study is published in the journal Internet Interventions.
Scientists develop a new hormone-free contraceptive
Researchers from KTH Royal Institute of Technology (KTH) and Karolinska Institutet are part of a collaborative study that has made progress in the testing of an innovative contraceptive method, a vaginal gel, that preclinical studies have shown prevents sperm from reaching the egg. The results are described in a paper published in the journal Science Translational Medicine.
Volunteers often first on the scene to save people with cardiac arrest
Volunteer SMS lifesavers in Sweden, who are alerted to cardiac arrests nearby using a mobile app, perform a large part of life-saving efforts before the ambulance, police or emergency services arrive, regardless if they are instructed to collect the nearest defibrillator or not. This is according to a new KI study published in JAMA Cardiology.
Grants and prizes
EU-funded research project takes broad approach on mental health
A major EU-funded research project, coordinated by Uppsala University, will pursue an interdisciplinary path towards better strategies to protect vulnerable individuals from mental illness. Three research teams at Karolinska Institutet participate in the project.
Martin Bergö addresses the debate about vitamin pills
Even as a child, Martin Bergö wanted to be a scientist. And he did. His biggest discovery so far is that vitamins can worsen the prognosis for cancer patients.
KI and Cancer Research Horizons announce 5-year partnership
Karolinska Institutet and Cancer Research UK’s innovation engine, Cancer Research Horizons, have announced a 5-year strategic partnership dedicated to accelerating the translation of academic cancer research into improved treatments for patients.
Positive media coverage of cannabis studies regardless of therapeutic effect
In cannabis trials against pain, people who take placebos report feeling largely the same level of pain relief as those who consume the active cannabinoid substance. Still, these studies receive significant media coverage regardless of the clinical outcome, report researchers from Karolinska Institutet in a study published in JAMA Network Open.
Cannabis is no better than placebo for treatment of pain
Reducing pain is one of the most common reasons people report using medical cannabis, but it's effectiveness remains in doubt. Now a meta-analysis from KI shows that there is no significant difference between cannabis and a placebo for reducing pain, and that postive media coverage of these trials may influence patient expectations.
Blood group can predict risk of contracting viral disease
The risk of being infected by parvovirus is elevated in those people who have blood group Rh(D), according to a study published in The Journal of Infectious Diseases by researchers from Karolinska Institutet in collaboration with Octapharma.
New Master's programme for Biomedical Scientists
Karolinska Institutet's programme of study is expanding. From autumn 2023, KI will offer a new Master's Programme in Biomedical Laboratory Science.
Immune cells in ALS patients can predict the course of the disease
By measuring immune cells in the cerebrospinal fluid when diagnosing ALS, it is possible to predict how fast the disease may progress according to a study from Karolinska Institutet published in Nature Communications.
Conferment ceremony brings glitter to autumn darkness
On 11 November, it was time once again for 99 new PhDs of medical science to receive their hats and diplomas at KI’s conferment ceremony. The evening also paid tribute to 17 jubilee doctors who graduated at KI 50 years ago.
Researchers may have found a new biomarker for acute COVID-19
Researchers at Karolinska Institutet have shown that patients with acute COVID-19 infection have increased levels of the cytokine IL-26 in their blood. Moreover, high IL-26 levels correlate with an exaggerated inflammatory response that signifies severe cases of the disease. The findings, which are presented in Frontiers in Immunology, indicate that IL-26 is a potential biomarker for severe COVID-19.
The Nobel Lecture in Physiology or Medicine 2022
On December 7 it's time for this year’s Nobel Lecture with the Nobel Prize Laureate in Physiology or Medicine 2022, Svante Pääbo. The lecture will take place in Aula Medica and will be broadcast live on nobelprize.org.
Selected top publications
Study shows how the brain encodes the start, duration and speed of locomotion
Eva M. Berg et al, Neuron, November 2022
Cholinesterase inhibitors helped Alzheimer’s patients preserve kidney function
Hong Xu et al, Kidney International, November 2022
New findings on the renewal of skin
Katie Cockburn et al, Nature Cell Biology, November 2022
New imaging marker reveals very early changes in Alzheimer’s disease
Milan Nemy et al, Brain, October 2022
Innovative coating on medical devices fights bacterial infections
Eleni Bletsa et al, Chemical Engineering Journal, October 2022
Patients with diverticular disease have increased cancer risk
Wenjie Ma et al, Journal of the National Cancer Institute, October 2022
More high impact publications
Scientific challenge to measure inequity in health
How is health equity even calculated? Researchers Emelie Agardh and Matteo Bottai at Karolinska Institutet are looking for new methodological paths, among other things inspired by the game Master mind.
Information regarding the war in Ukraine
On this page you will find information for staff and students and resources for journalists and the public concerning Russia’s invasion of Ukraine.
The Macchiarini case: timeline
KI in the debate
KI constantly engages in the public debate and comments on current issues concerning our operations. On this page you find published opinion pieces and comments.